IMA is loading

Main Financial Data 2015

Main Data: 31/12 Year 2015
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 1,109.54
– gross industrial income 420.77
– total operating cost 305.15
– operating profit 115.62
– net financial expenses 1.04
– profit attributable to equity holders of the parent 69.92

 

 

Consolidated balance sheet Millions/Euro
– working capital 13.99
– non-current assets 420.00
– provision for severance indemnities and other provisions – 95.09
– net debt – 163.12
– equity pertaining to the group and minority interests 175.78

 

Other information  Millions/Euro
– depreciation, amortization and impairment 32.52
– R & D costs 40.05

 

  Euro
Dividend per share 1.35

 

  No.
Employees 4,576

 

  Euro
Share capital 19,505,200

 

Main Data: 30/06 Year 2015
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 481.2
– gross industrial income 182.2
– total operating cost 151.0
– operating profit 31.2
– net financial expenses 9.7
– profit attributable to equity holders of the parent 11.4

 

Consolidated balance sheet Millions/Euro
– working capital 37.1
– non-current assets 428.0
– provision for severance indemnities and other provisions – 96.7
– net debt – 255.3
– equity pertaining to the group and minority interests  113.1

 

Other information Millions/Euro
– depreciation, amortization and impairment 14.3
– R & D costs 19.9

 

  No.
Employees 4,392

 

  Euro
Share Capital 19,505,200

 

Net Sales by Sector: Year 2015
  Millions/Euro  
tea, food & other 590.46 53.2%
pharmaceutical 519.08 46.8%
Total 1,109.54 100.0%

 

Net Sales by Country: Year 2015
  Millions/Euro  
E.U. (excluding Italy) 352.71 31.8%
Other European countries 68.89 6.2%
North America 223.42 20.1%
Asia & Middle East 227.77 20.5%
Other countries 118.26 10.7%
Total exports 991.05 89.3%
Italy 118.49 10.7%
Total 1,109.54 100.0%
Dismissclose

IMA Pharma
@ Achema

Explore the dedicated website and get a free entry pass with IMA